glow ghk-cu injection for Skin Rejuvenation GHK-Cu Peptide: Benefits for Tissue
Description
When their seminal research was published in *Cell* in March 2017, it introduced the first precision senolytic peptide capable of selectively eliminating senescent cells while sparing healthy tissue, opening unprecedented opportunities for studying aging mechanisms and developing research tools for age-related cellular dysfunction
It has not been approved by the FDA or any other regulatory authority for medical or clinical use
Injection site reactions including pain, swelling, or redness
Serving Size:1 Capsule
